Search clinical trials for: Nintedanib (Ofev®)
Total 13828 results
-
Boehringer IngelheimActive, not recruitingLung Diseases, InterstitialUnited States, Spain, United Kingdom, Canada, Finland, Norway, Italy, Argentina, Belgium, Brazil, Czechia, France, Greece, Mexico, Poland, Germany, Portugal
-
Boehringer IngelheimNo longer availableLung Diseases, Interstitial (in Pediatric Populations) | Childhood Interstitial Lung Disease (chILD)
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHealthyUnited Kingdom
-
Boehringer IngelheimNo longer available
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States
-
Boehringer IngelheimActive, not recruiting
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityNot yet recruiting
-
Boehringer IngelheimRecruiting
-
Boehringer IngelheimCompletedLung Diseases, InterstitialUnited States, Spain, United Kingdom, Canada, Australia, Italy, Hungary, Finland, Denmark, Norway, Argentina, Russian Federation, Portugal, Belgium, Brazil, Czechia, France, Greece, Mexico, Poland, Ukraine
-
McGill University Health Centre/Research Institute...RecruitingInterstitial Lung Disease | Myopathy, InflammatoryCanada
-
Holdsworth House Medical PracticeBoehringer IngelheimRecruitingSilicosis | Pneumoconiosis Coal | AsbestosisAustralia
-
Assistance Publique - Hôpitaux de ParisBoehringer IngelheimRecruitingSARS-Cov-2 Induced Pulmonary FibrosisFrance
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingNon Small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | Lung Cancer, Nonsmall CellUnited States
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisKorea, Republic of
-
IRCCS MultimedicaCompleted
-
Boehringer IngelheimActive, not recruitingLung Diseases, InterstitialJapan
-
West Virginia UniversityNot yet recruitingProgressive Fibrosing Interstitial Lung DiseaseUnited States
-
University of Texas Southwestern Medical CenterBoehringer Ingelheim; South Plains Oncology Consortium; The University of Texas...Active, not recruitingCancer of PancreasUnited States
-
Boehringer IngelheimActive, not recruiting
-
Rohit Aggarwal, MDBoehringer IngelheimRecruitingMyositis Associated Interstitial Lund Disease (MA-ILD)United States
-
Washington University School of MedicineNational Comprehensive Cancer NetworkActive, not recruitingCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Nonsmall Cell Lung CancerUnited States
-
Temple UniversityBoehringer IngelheimTerminatedIdiopathic Pulmonary Fibrosis | Lung Transplant; ComplicationsUnited States
-
Hal ChapmanMassachusetts General Hospital; University of Michigan; University of Washington and other collaboratorsRecruitingIdiopathic Pulmonary FibrosisUnited States
-
Boehringer IngelheimCompleted
-
Centre Oscar LambretBoehringer IngelheimCompleted
-
Boehringer IngelheimApproved for marketingLung Diseases, InterstitialUnited States
-
Boehringer IngelheimCompletedCarcinoma, HepatocellularJapan
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Canada, Denmark, France, Germany, Italy, Netherlands, Spain
-
Wake Forest University Health SciencesBoehringer IngelheimTerminated
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisSpain, Korea, Republic of, Belgium, Czechia, Australia, Germany, United Kingdom, United States, France, Finland, Japan, Poland, Hungary
-
Boehringer IngelheimApproved for marketingIdiopathic Pulmonary FibrosisUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedRecurrent Pleural Malignant Mesothelioma | Stage IV Pleural MesotheliomaUnited States
-
Boehringer IngelheimNo longer availableIdiopathic Pulmonary FibrosisBrazil
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenocarcinoma | Endometrial Transitional Cell Carcinoma | Endometrial Mucinous Adenocarcinoma | Endometrial Squamous Cell Carcinoma | Malignant Uterine Corpus Mixed Epithelial and Mesenchymal NeoplasmUnited States
-
Boehringer IngelheimActive, not recruitingLung Diseases, InterstitialChina
-
Huilan ZhangUnknownCOVID-19 | Safety | Effect of Drugs | Nintedanib
-
Endeavor Biomedicines, Inc.CompletedIdiopathic Pulmonary FibrosisAustralia
-
Boehringer IngelheimCompletedColorectal NeoplasmsUnited States, Argentina, Australia, Austria, Belgium, Canada, Czechia, Denmark, France, Germany, Hong Kong, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Poland, Portugal, Russian Federation, Spain, Sweden, Taiwan, T... and more
-
FibroGenCompletedIdiopathic Pulmonary FibrosisUnited States, New Zealand, India, South Africa, Australia, Bulgaria, Canada
-
University College, LondonBoehringer IngelheimCompletedOvarian Cancer | Fallopian Tube CancerUnited Kingdom
-
Boehringer IngelheimCompleted
-
University Hospital, LimogesBoehringer IngelheimCompleted
-
AIO-Studien-gGmbHCompleted
-
Vicore Pharma ABCompletedDrug InteractionSweden
-
Yale UniversityVanderbilt UniversityCompletedRelapsed/Refractory Acute Myeloid LeukemiaUnited States
-
Boehringer IngelheimTerminatedCarcinoma, Non-Small-Cell LungUnited States, Georgia, Thailand
-
Hospices Civils de LyonRecruitingProgressive Idiopathic Pulmonary FibrosisFrance
-
Prof. Dr. med. Dirk SchadendorfBoehringer Ingelheim; medac GmbH; Alcedis GmbHCompletedCutaneous Malignant MelanomaGermany
-
China Medical University HospitalNot yet recruitingNon-small Cell Lung Cancer | EGFR Gene Mutation | EGFR-TKI Resistant Mutation